Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Flibanserin by Sprout2 for Male Hypoactive Sexual Desire Disorder: Likelihood of Approval
Flibanserin is under clinical development by Sprout2 and currently in Phase II for Male Hypoactive Sexual Desire Disorder. According to...